However, AD pathology extends beyond amyloid and tau, encompassing a multifaceted array of pathophysiological mechanisms, including chronic neuroinflammation, oxidative stress, mitochondrial dysfunction, impaired proteostasis (the homeostasis of protein folding, stability, and degradation), calcium dysregulation, excitotoxicity, and breakdown of the blood-brain barrier (BBB) [16, 17]
Semaglutide and tirzepatide reduce systemic inflammation and improve endothelial function, both protective factors for renal tissue
Tirzepatide data comes from the SURMOUNT-1 trial with 2,539 participants over 72 weeks
How Our Liposomal Glutathione Development Solves These Issues: Enhanced Stability: The lipid bilayer creates a physical barrier against oxygen and UV light, preserving the reduced state of glutathione
One patient had unique nested areas composed of mature glial tissue